MyAverix Finance
US · Healthcare
Oryzon Genomics S.A (ORYZF)
Biotechnology
Oryzon Genomics S.A (ORYZF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ORYZF
Oryzon Genomics S.A (ORYZF) — FAQ
What is ORYZF's P/E ratio?
The price-to-earnings (P/E) ratio for Oryzon Genomics S.A (ORYZF) is 18.00 (data as of 2026-03-24).
Does Oryzon Genomics S.A pay a dividend?
Dividend yield is not available in the current snapshot for Oryzon Genomics S.A (ORYZF). Check the MyAverix Finance app for the latest dividend data.
What sector is Oryzon Genomics S.A in?
Oryzon Genomics S.A (ORYZF) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ORYZF listed on?
ORYZF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.